TY  - GEN
AU  - Ma,Jennifer S Y
AU  - Kim,Ji Young
AU  - Kazane,Stephanie A
AU  - Choi,Sei-Hyun
AU  - Yun,Hwa Young
AU  - Kim,Min Soo
AU  - Rodgers,David T
AU  - Pugh,Holly M
AU  - Singer,Oded
AU  - Sun,Sophie B
AU  - Fonslow,Bryan R
AU  - Kochenderfer,James N
AU  - Wright,Timothy M
AU  - Schultz,Peter G
AU  - Young,Travis S
AU  - Kim,Chan Hyuk
AU  - Cao,Yu
TI  - Versatile strategy for controlling the specificity and activity of engineered T cells
SN  - 1091-6490
PY  - 2016///0613
KW  - Animals
KW  - Antigens, CD19
KW  - immunology
KW  - Antigens, Neoplasm
KW  - Azides
KW  - B-Lymphocytes
KW  - Cell Line, Tumor
KW  - Cytotoxicity, Immunologic
KW  - Female
KW  - Fluorescein-5-isothiocyanate
KW  - Genetic Vectors
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - adverse effects
KW  - Lentivirus
KW  - genetics
KW  - Leukemia, B-Cell
KW  - therapy
KW  - Lymphocyte Activation
KW  - Lymphopenia
KW  - etiology
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Inbred NOD
KW  - Mice, SCID
KW  - Models, Molecular
KW  - Phenylalanine
KW  - analogs & derivatives
KW  - Protein Conformation
KW  - Protein Engineering
KW  - methods
KW  - Receptors, Antigen, T-Cell
KW  - Recombinant Fusion Proteins
KW  - Sialic Acid Binding Ig-like Lectin 2
KW  - Single-Chain Antibodies
KW  - T-Cell Antigen Receptor Specificity
KW  - T-Lymphocytes
KW  - Transduction, Genetic
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1073/pnas.1524193113
ER  -